Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

ISSN： 1460-2156

Source： Brain, Vol.126, Iss.10, 2003-10, pp. : 2191-2202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Mitochondrial Component of Neurodegeneration in Multiple Sclerosis

By Kalman Bernadette Leist Thomas P.

NeuroMolecular Medicine, Vol. 3, Iss. 3, 2003-06 ,pp. : 147-158

Humana Press, Inc

Access to resources Recommend Favorite

The relation between inflammation and neurodegeneration in multiple sclerosis brains

By Frischer Josa M.

Brain, Vol. 132, Iss. 5, 2009-05 ,pp. : 1175-1189

Oxford University Press

Access to resources Recommend Favorite

An examination of four models predicting fatigue in multiple sclerosis

By Strober Lauren B. Arnett Peter A.

Archives of Clinical Neuropsychology, Vol. 20, Iss. 5, 2005-07 ,pp. : 631-646

Oxford University Press

Access to resources Recommend Favorite

The value of animal models for drug development in multiple sclerosis

By Friese Manuel A. Montalban Xavier Willcox Nick Bell John I. Martin Roland Fugger Lars

Brain, Vol. 129, Iss. 8, 2006-08 ,pp. : 1940-1952

Oxford University Press

Access to resources Recommend Favorite

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis

By Metz Imke

Brain, Vol. 130, Iss. 5, 2007-05 ,pp. : 1254-1262

Oxford University Press

Access to resources Recommend Favorite